These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21855607)

  • 1. Pyruvate therapy for mitochondrial DNA depletion syndrome.
    Saito K; Kimura N; Oda N; Shimomura H; Kumada T; Miyajima T; Murayama K; Tanaka M; Fujii T
    Biochim Biophys Acta; 2012 May; 1820(5):632-6. PubMed ID: 21855607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study.
    Fujii T; Nozaki F; Saito K; Hayashi A; Nishigaki Y; Murayama K; Tanaka M; Koga Y; Hiejima I; Kumada T
    Mol Genet Metab; 2014 Jun; 112(2):133-8. PubMed ID: 24830361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
    Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
    Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
    Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
    Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate Improved Insulin Secretion Status in a Mitochondrial Diabetes Mellitus Patient.
    Inoue T; Murakami N; Ayabe T; Oto Y; Nishino I; Goto Y; Koga Y; Sakuta R
    J Clin Endocrinol Metab; 2016 May; 101(5):1924-6. PubMed ID: 26885883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency.
    Komaki H; Nishigaki Y; Fuku N; Hosoya H; Murayama K; Ohtake A; Goto Y; Wakamoto H; Koga Y; Tanaka M
    Biochim Biophys Acta; 2010 Mar; 1800(3):313-5. PubMed ID: 19616603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
    Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
    Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene.
    Koga Y; Povalko N; Katayama K; Kakimoto N; Matsuishi T; Naito E; Tanaka M
    Brain Dev; 2012 Feb; 34(2):87-91. PubMed ID: 21454027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report.
    Montero R; Sánchez-Alcázar JA; Briones P; Navarro-Sastre A; Gallardo E; Bornstein B; Herrero-Martín D; Rivera H; Martin MA; Marti R; García-Cazorla A; Montoya J; Navas P; Artuch R
    Clin Biochem; 2009 May; 42(7-8):742-5. PubMed ID: 19094978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of pyruvate therapy for mitochondrial diseases.
    Tanaka M; Nishigaki Y; Fuku N; Ibi T; Sahashi K; Koga Y
    Mitochondrion; 2007 Dec; 7(6):399-401. PubMed ID: 17881297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mitochondrial diseases in children including Leigh syndrome--biochemical and molecular background].
    Pronicka E; Piekutowska-Abramczuk D; Pronicki M
    Postepy Biochem; 2008; 54(2):161-8. PubMed ID: 18807927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
    Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
    Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients.
    Navarro-Sastre A; Tort F; Garcia-Villoria J; Pons MR; Nascimento A; Colomer J; Campistol J; Yoldi ME; López-Gallardo E; Montoya J; Unceta M; Martinez MJ; Briones P; Ribes A
    Mol Genet Metab; 2012 Nov; 107(3):409-15. PubMed ID: 22980518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations.
    Roos S; Lindgren U; Ehrstedt C; Moslemi AR; Oldfors A
    Neuromuscul Disord; 2014 Aug; 24(8):713-20. PubMed ID: 24953930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with congenital hyperlactataemia and Leigh syndrome: an uncommon mitochondrial variant.
    Ching CK; Mak CM; Au KM; Chan KY; Yuen YP; Yau EK; Ma LC; Chow HL; Chan AY
    Hong Kong Med J; 2013 Aug; 19(4):357-61. PubMed ID: 23918514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations.
    El-Hattab AW; Li FY; Schmitt E; Zhang S; Craigen WJ; Wong LJ
    Mol Genet Metab; 2010 Mar; 99(3):300-8. PubMed ID: 20074988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral energy metabolism during induced mitochondrial dysfunction.
    Nielsen TH; Bindslev TT; Pedersen SM; Toft P; Olsen NV; Nordström CH
    Acta Anaesthesiol Scand; 2013 Feb; 57(2):229-35. PubMed ID: 23017022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile-onset disorders of mitochondrial replication and protein synthesis.
    Nogueira C; Carrozzo R; Vilarinho L; Santorelli FM
    J Child Neurol; 2011 Jul; 26(7):866-75. PubMed ID: 21572058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene.
    Oskoui M; Davidzon G; Pascual J; Erazo R; Gurgel-Giannetti J; Krishna S; Bonilla E; De Vivo DC; Shanske S; DiMauro S
    Arch Neurol; 2006 Aug; 63(8):1122-6. PubMed ID: 16908738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeutics.
    Foriel S; Willems P; Smeitink J; Schenck A; Beyrath J
    Int J Biochem Cell Biol; 2015 Jun; 63():60-5. PubMed ID: 25666557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.